Addiction and Neurodegenerative Disorders
Unraveling the Nexus
Herausgeber: El Hayek, Samer
Addiction and Neurodegenerative Disorders
Unraveling the Nexus
Herausgeber: El Hayek, Samer
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book explores the connection between neurodegenerative disorders and addiction. It delves into the complex interplay between the two areas, discussing preclinical to clinical findings that highlight commonalities, shared risk factors, interplay and causality, comorbidity, management, and evidence-based interventions.
Andere Kunden interessierten sich auch für
Music and Altered States37,99 €
Valentin SusannaMein letzter Rausch24,00 €
SpringerSuchtkrankheit79,99 €
Peter MorrallSociology and Nursing56,99 €
Pasquale ArpaiaWearable Brain-Computer Interfaces168,99 €
Sucht im Alter - Maßnahmen und Konzepte für die Pflege54,99 €
Daniel IllyRatgeber Videospiel- und Internetabhängigkeit21,00 €-
-
-
This book explores the connection between neurodegenerative disorders and addiction. It delves into the complex interplay between the two areas, discussing preclinical to clinical findings that highlight commonalities, shared risk factors, interplay and causality, comorbidity, management, and evidence-based interventions.
Produktdetails
- Produktdetails
- Verlag: CRC Press
- Seitenzahl: 246
- Erscheinungstermin: 29. Juli 2025
- Englisch
- Abmessung: 260mm x 183mm x 18mm
- Gewicht: 665g
- ISBN-13: 9781032762425
- ISBN-10: 103276242X
- Artikelnr.: 73328666
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: CRC Press
- Seitenzahl: 246
- Erscheinungstermin: 29. Juli 2025
- Englisch
- Abmessung: 260mm x 183mm x 18mm
- Gewicht: 665g
- ISBN-13: 9781032762425
- ISBN-10: 103276242X
- Artikelnr.: 73328666
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Dr. Samer El Hayek, MD, is a specialist psychiatrist at the American Center for Psychiatry and Neurology, Dubai, United Arab Emirates, and an adjunct assistant professor of clinical psychiatry at the American University of Beirut Medical Center (AUBMC), Beirut, Lebanon. An accomplished adult and addiction psychiatrist, Dr. El Hayek brings a robust clinical, academic, and research background to his work. Dr. El Hayek completed a fellowship in addiction psychiatry at the University of Miami-Jackson Health System in Miami, Florida, United States, in 2022, following a clinical psychiatry residency at AUBMC. With over three years of focused experience in addiction psychiatry, Dr. El Hayek has developed expertise in managing dual diagnoses and implementing patient-centered, multidisciplinary approaches. His clinical practice is informed by his extensive work with individuals from various cultural and socioeconomic backgrounds, underscoring his global perspective and dedication to reducing mental health disparities. A passionate researcher and thought leader, Dr. El Hayek has authored over 85 peer-reviewed publications, with research interests spanning global mental health, addiction, and stigma. His scholarly contributions have been cited more than 2,000 times, earning him an h-index of 22 by 2024. His research achievements were recognized by his induction into Sigma Xi, The Scientific Research Honor Society, in 2023. He is also the recipient of several awards, including the 2023 Yearly Research Contribution Award from the Erada Center for Treatment and Rehabilitation in Dubai, the 2019 Early-Career Psychiatrists Award from the 15th International Congress on Psychiatry at Ain Shams University in Cairo, and the 2019 Asian Federation of Psychiatric Associations Fellowship Award for Young Psychiatrists at the 7th World Congress of Asian Psychiatry in Melbourne, Australia. Dr. El Hayek is a board member and the Eastern Mediterranean Region representative for the Network of Early-Career Professionals Working in Addiction Medicine (NECPAM). He also holds editorial roles in several scientific journals, including Frontiers in Public Health and Current Psychopharmacology.
1. Animal models of substance use and neurodegeneration 2. Parkinson's
disease and drug addiction 3. Alzheimer's disease and drug addiction 4.
Frontotemporal dementia and drug addiction 5. Alcohol and neurodegenerative
disorders 6. Cannabis and neurodegenerative disorders 7. Opioids and
neurodegenerative disorders 8. Sedatives, hypnotics, and anxiolytics and
neurodegenerative disorders 9. Stimulants and neurodegenerative disorders
10. Tobacco and neurodegenerative disorders 11. Behavioral addictions in
neurodegenerative diseases 12. Interventions for addiction in
neurodegenerative disorders 13. Psychedelic-inspired approaches for
treating neurodegenerative disorders.14. PsychedelicInspired Approaches for
Treating Neurodegenerative Disorders 15. Environmental Factors and
Challenges in Managing Addiction and Neurodegenerative Disorders 16.
Challenges of Neurodegenerative and Substance Use Disorders in Low and
MiddleIncome Countries 16. Challenges of Neurodegenerative and Substance
Use Disorders in Low and MiddleIncome Countries
disease and drug addiction 3. Alzheimer's disease and drug addiction 4.
Frontotemporal dementia and drug addiction 5. Alcohol and neurodegenerative
disorders 6. Cannabis and neurodegenerative disorders 7. Opioids and
neurodegenerative disorders 8. Sedatives, hypnotics, and anxiolytics and
neurodegenerative disorders 9. Stimulants and neurodegenerative disorders
10. Tobacco and neurodegenerative disorders 11. Behavioral addictions in
neurodegenerative diseases 12. Interventions for addiction in
neurodegenerative disorders 13. Psychedelic-inspired approaches for
treating neurodegenerative disorders.14. PsychedelicInspired Approaches for
Treating Neurodegenerative Disorders 15. Environmental Factors and
Challenges in Managing Addiction and Neurodegenerative Disorders 16.
Challenges of Neurodegenerative and Substance Use Disorders in Low and
MiddleIncome Countries 16. Challenges of Neurodegenerative and Substance
Use Disorders in Low and MiddleIncome Countries
1. Animal models of substance use and neurodegeneration 2. Parkinson's
disease and drug addiction 3. Alzheimer's disease and drug addiction 4.
Frontotemporal dementia and drug addiction 5. Alcohol and neurodegenerative
disorders 6. Cannabis and neurodegenerative disorders 7. Opioids and
neurodegenerative disorders 8. Sedatives, hypnotics, and anxiolytics and
neurodegenerative disorders 9. Stimulants and neurodegenerative disorders
10. Tobacco and neurodegenerative disorders 11. Behavioral addictions in
neurodegenerative diseases 12. Interventions for addiction in
neurodegenerative disorders 13. Psychedelic-inspired approaches for
treating neurodegenerative disorders.14. PsychedelicInspired Approaches for
Treating Neurodegenerative Disorders 15. Environmental Factors and
Challenges in Managing Addiction and Neurodegenerative Disorders 16.
Challenges of Neurodegenerative and Substance Use Disorders in Low and
MiddleIncome Countries 16. Challenges of Neurodegenerative and Substance
Use Disorders in Low and MiddleIncome Countries
disease and drug addiction 3. Alzheimer's disease and drug addiction 4.
Frontotemporal dementia and drug addiction 5. Alcohol and neurodegenerative
disorders 6. Cannabis and neurodegenerative disorders 7. Opioids and
neurodegenerative disorders 8. Sedatives, hypnotics, and anxiolytics and
neurodegenerative disorders 9. Stimulants and neurodegenerative disorders
10. Tobacco and neurodegenerative disorders 11. Behavioral addictions in
neurodegenerative diseases 12. Interventions for addiction in
neurodegenerative disorders 13. Psychedelic-inspired approaches for
treating neurodegenerative disorders.14. PsychedelicInspired Approaches for
Treating Neurodegenerative Disorders 15. Environmental Factors and
Challenges in Managing Addiction and Neurodegenerative Disorders 16.
Challenges of Neurodegenerative and Substance Use Disorders in Low and
MiddleIncome Countries 16. Challenges of Neurodegenerative and Substance
Use Disorders in Low and MiddleIncome Countries







